Biobetters a big opportunity for biopharm and CROs Biobetters a big opportunity for biopharm and CROs 12-Apr-2011 By Nick Taylor Biobetters, more than biosimilars, are the big opportunity for biopharm and CROs hoping to profit from biologics patent expirations, say experts.